Abstract Binge drinking affects the onset and progression of human immunodeficiency virus (HIV)-associated neurological disorders. The HIV-1 transgenic (HIV-1Tg) rat was created with a gag-and pol-deleted HIV-1 viral genome to mimic HIV-infected patients receiving combination anti-retroviral therapy (cART). Docosahexaenoic acid (DHA) is a marine compound that modulates inflammatory responses. Using HIV-1Tg rats subjected to binge exposure to ethanol (EtOH), this study examined whether DHA could reduce the detrimental neurological effects of EtOH and HIV proteins. Young adult male HIV-1Tg and F344 control rats received 4 mL/kg/ day saline as a control (Saline group), 20 mg/kg/day DHA (DHA group), 4.8 g/kg/day 52% w/v EtOH (EtOH group), or 4.8 g/kg/day 52% w/v EtOH and 20 mg/kg/d DHA (DHA + EtOH group) by gavage for 5 weeks (n = 6 per group). EtOH was administrated on days 5, 6, and 7 of each week.
Introduction
Alcohol is the most widely used addictive substance in the world. Alcohol consumption raises considerable public health concerns and is a leading cause of suffering globally (Davoren et al. 2016) . Alcohol abuse can produce significant alterations in brain structure and ultimately lead to neuropsychological disorders and behavioral dysfunction (Sanhueza et al. 2011; Yang et al. 2014) . Binge drinking, particularly of hard liquor (more than 40% alcohol by volume), is common among college students. It can lead to learning and cognitive deficits and seriously impact a student's academic performance (Johnston et al. 2014; Siegel et al. 2013; Siegel et al. 2011) . College students fall within the period of late adolescence to young adulthood when critical structural and functional maturation of the central nervous system (CNS) occurs (Silveri 2012) . Ethanol (EtOH) is the key component in alcoholic beverages that produces alcohol's effects. As EtOH can infuse into all cells, alcohol consumption can potentially affect all systems within the body, including the immune system and the CNS (Prendergast and Little 2007) . Therefore, alcohol use and abuse during college years, particularly binge drinking, is a major concern.
The striatum is a key brain region responsible for voluntary motor control, which can be experimentally assessed by evaluating locomotor activity (LMA) (Baez-Mendoza and Schultz 2013) . The striatum is also part of the brain's reward circuit, and levels of various mediators in the striatum, such as cyclic AMP (cAMP), nerve growth factors, and inflammatory cytokines, have been suggested to integrate actions with rewards, as may occur with drinking alcohol (Aarli 2003; BaezMendoza and Schultz 2013; Bie et al. 2012; Crews and Vetreno 2016; Wrona 2006) . About two decades ago, Meng et al. reported that modulation of cAMP in the striatum was involved in acute EtOH-induced motor impairment (Meng et al. 1998) . Modulation of cAMP can affect many biological and pathological responses, including various inflammatory responses (Pociecha et al. 2015; Shu et al. 2016; Wang et al. 2003; Wang et al. 2017) . Inflammation within the CNS, including the striatum, has been identified as one of the mechanisms underlying the neuronal dysfunction that can lead to behavioral disorders (Aarli 2003; Covacu and Brundin 2015) .
Furthermore, the prevalence of alcohol use and alcohol abuse in specific populations, such as human immunodeficiency virus (HIV)-infected individuals, is much higher than that of the general population in the USA . Numerous studies have shown that EtOH and HIV-1 viral proteins have synergistic effects on inflammation in the CNS (Acheampong et al. 2002; Flora et al. 2005; Nair et al. 2015) . HIV is a lentivirus that replicates by infecting and destroying primarily CD4+ T cells, a subset of lymphocytes essential for normal function of the immune system. The end-stage of HIV viral progression is acquired immune deficiency syndrome (AIDS) (Kaplan et al. 2009 ). HIV-1 gp120 and Tat proteins alter tight junctions and brain endothelial cell permeability (Kanmogne et al. 2005) . HIV-1 Nef protein produces neurotoxicity associated with cognitive deficits. Abundant expression of HIV-1 Nef and Rev proteins in brain astrocytes in vivo has been associated with dementia (Ranki et al. 1995) . Treatment with combination anti-retroviral therapy (cART), which specifically inhibits assembly of HIV viral proteins and the activity of reverse transcriptase, has successfully limited the progression of HIV-1 to AIDS.
An HIV-1 transgenic (HIV-1Tg) rat model was created about two decades ago (Reid et al. 2001) . The HIV-1Tg rat carries the env gene and six supplementary genes-tat, rev, vif, vpr, vpu, and nef-but the gag and pol genes, which are essential for assembly and reverse transcription, are deleted (Reid et al. 2001) . Thus, the HIV-1Tg rat mimics HIV patients receiving cART and has been used for investigating the effects of long-term HIV-1 viral protein exposure in HIV-1-associated neuroinflammation and behavioral alterations (Vigorito et al. 2015) . Despite a lack of viral replication, viral proteins are continually expressed throughout the animal's life (Abbondanzo and Chang 2014; Peng et al. 2010) .
Docosahexaenoic acid (DHA) is a long-chain polyunsaturated fatty acid considered essential for maturation of the developing brain, retina, and other organs in newborn infants (Anderson et al. 1990; Jasani et al. 2017; Simopoulos 1991) . DHA concentration is reported to be affected by estrogens (Giltay et al. 2004 ). Thus, women reportedly have a higher circulating DHA concentration than men (Giltay et al. 2004) . During pregnancy, the maternal DHA concentration increases (Otto et al. 2001; Postle et al. 1995) . DHA is poorly synthesized de novo (Menard et al. 1998 ) and a dietary supplement is necessary to substantially increase levels. Dietary DHA has been shown to exert beneficial effects on neuronal development, as well as neuroprotective properties (Dyall 2015; Lauritzen et al. 2016) . Depletion of DHA is associated with various neurological abnormalities, such as anxiety, irritability, susceptibility to stress, impaired memory and cognitive functions, and extended reaction times (Cardoso et al. 2016) . However, the modulatory effects of DHA on voluntary motor control or LMA have not been previously studied.
Based on this information, we hypothesized that daily treatment with DHA could reverse the effects of binge exposure to EtOH on LMA in the presence of HIV viral proteins. To avoid interference due to estrogen, male rats were used in this study. We first examined how repeated binge EtOH exposure affects LMA of HIV-1Tg and control F344 adolescent rats. Then, we studied whether concurrent treatment with DHA can reverse the effects of EtOH on LMA and alter the inflammatory cytokine profile in the striatum of these animals. Our data show that daily DHA consumption, possibly via its antiinflammatory effects, can partially reverse the adverse effects of binge EtOH exposure on behavioral performance.
Materials and methods

Animals
To avoid the interference of sex hormones on DHA, male rats were used in the study. Male F344 (control) and HIV-1Tg rats were purchased from Harlan Inc. (Indianapolis, IN, USA) . The rats were housed with four animals per ventilated plastic rat cage (Animal Care Systems Inc., Centennial, CO) and maintained in a temperature-and humidity-controlled environment. They were maintained in a 12-h light/dark cycle and fed a standard rat diet. The experimental protocol was approved by the Institutional Animal Care and Use Committee (IACUC) at Seton Hall University, South Orange, NJ.
Ethanol and docosahexaenoic acid administration
Treatment began when the animals were 7 weeks old. The rats were randomly divided into four groups (n = 6) for each strain and treated by intragastric administration of saline as a control (Saline group), DHA (DHA group), EtOH (EtOH group), or DHA combined with EtOH (DHA + EtOH group). The DHA solution was prepared by dissolving DHA (Nu-chek Prep, Elysian, MN) in saline. The DHA solution was shaken vigorously for 2 min before use. The Saline group was treated with 4 mL/kg saline daily. The DHA group was treated with 20 mg/ kg DHA daily. The EtOH group was treated with 4 mL/kg/day saline on day 1 to day 4 from week 1 to week 5. In the first week, the dosage of EtOH was gradually increased from 1 g/kg on day 5 to 2 g/kg on day 6 and 4.8 g/kg on day 7 to allow the rats to adapt to high-dose EtOH. The EtOH dosage remained at 4.8 g/kg from week 2 to week 5, administered on day 5 to day 7 of each week (Fig. 1a) . The DHA + EtOH group was administered 20 mg/kg/d DHA on day 1 to day 7, and, on day 5 to day 7, EtOH was administered 1 h after DHA injection using the same dosage escalation schedule as in the EtOH group. At the end of 5 weeks of treatment, the rats were sacrificed (at 12 weeks of age). Whole blood was collected via cardiac puncture and stored in blood collection tubes with lithium heparin (BD, Franklin Lakes, NJ). The brains were microdissected, and the striatum regions were used for analysis of gene expression using quantitative reverse-transcriptase-polymerase chain reaction (qRT-PCR).
Locomotor activity measurement
LMA in the open field apparatus was measured using a video tracking software (Stoelting ANY-maze, Wood Dale, IL) for a 2-min period prior to and at 45, 90, 135, and 180 min, respectively, after EtOH injection on every EtOH treatment day (Fig. 1b) . The animals were given the intragastric treatments on the day of sacrifice and placed in the open field apparatus for 10 min prior to sacrifice.
Plasma endotoxin determination
Plasma was prepared by centrifuging the whole blood for 10 min at 2000×g at 4°C. The supernatant was transferred immediately to endotoxin-free tubes by serological pipettes and stored at − 80°C before use. Endotoxin in the plasma of each sample was measured using the Pyrogent-5000 Kinetic Turbidimetric Assay (Lonza, Walkersville, MD), according to the manufacturer's instruction.
RNA isolation and cDNA preparation
Total RNA was extracted from the striatum using an RNeasy Mini Kit (Qiagen, Valencia, CA), followed by RNase-free DNase (Qiagen, Valencia, CA) to remove contaminating DNA. RNA quality and quantity were determined using the ND1000 Nanodrop spectrophotometer (Thermo Scientific, Waltham, MA). An equal amount of RNA (200 ng) from each sample was then converted to cDNA using a RT 2 First Strand Kit (SABiosciences, Frederick, MD), according to the manufacturer's instructions.
Real-time quantitative polymerase chain reaction analysis
Quantification of gene expression was performed using RT 2 SYBR Green Fluorescein qPCR Master Mix (SABiosciences, Frederick, MD), according to the manufacturer's instructions. Real-time polymerase chain reaction (PCR) was performed using the ABI Prism 7900HT Fast Detection System (Applied Biosystems, Foster, CA). The PCR mix was denatured at 95°C for 10 min before the first PCR cycle. The thermocycler parameters were 95°C for 10 min, followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. β-actin (ACTB) and splicing factor, arginine/serine-rich 4 (SFRS4) were used as housekeeping genes. The primer sequences are shown in Table 1 .
Statistical analysis
A preliminary review of the LMA data revealed that the distance traveled during the 2 min before daily treatments and the total distances traveled after the daily treatments displayed different patterns of behavior change over weeks. For that reason, the two LMA data sets were analyzed separately using the same statistical analysis as described below.
Due to occasional difficulty with intragastric administration, data points were not available for all rats on every day of treatment. In addition, some rats died before they could complete the full 5 weeks of treatment. Therefore, to analyze the change in LMA with repeated treatment, the LMA data were collapsed into three treatment blocks: block 1 (week 1), block 2 (weeks 2 and 3, Wk2&3), and block 3 (weeks 4 and 5, Wk4&5). Five rats were dropped from the analysis because data points were not available for all three blocks. No more than one rat was dropped from a group ( Table 2 ). The final number of rats per groups was: HIV-1Tg Saline (n = 5), HIV1Tg DHA (n = 6), HIV-1Tg EtOH (n = 5), HIV-1Tg DHA + EtOH (n = 5), F344 Saline (n = 6), F344 DHA (n = 5), F344 EtOH (n = 5), and F344 DHA + EtOH (n = 6).
For each genotype, two groups received EtOH (EtOH group and DHA + EtOH group) and two groups did not receive EtOH (Saline group and DHA group). In addition for each genotype, each group received DHA (DHA group and DHA + EtOH group) and two groups did not receive DHA (Saline group and EtOH group). Thus, the data were analyzed as a Genotype (2) × EtOH (2) × DHA (2) × blocks (3) mixed ANOVA with blocks as the repeated measure and the three other factors as between-groups factors, followed by three-way and two-way ANOVAs and Tukey post hoc t tests where appropriate. Plasma endotoxin concentrations were analyzed using two-way ANOVA.
Results
Distance traveled during the 2 min before treatment reveals long-term effects of EtOH on locomotor activity in both F344 and HIV-1Tg and a DHA effect in HIV-1Tg rats , and DHA + EtOH groups during each week. The Saline group was treated with 4 mL/kg saline daily. The EtOH group was treated with 4 mL/kg/d saline on day 1 to day 4 of every week; during the first week, they were treated with 1 g/ kg 52% w/v ethanol (EtOH) on day 5, 2 g/kg 52% w/v EtOH on day 6, and 4.8 g/kg on day 7, and from weeks 2 to 5 were treated with 4.8 g/kg/day 52% w/v EtOH on day 5 to day 7. The DHA group was treated with 20 mg/kg docosahexaenoic acid (DHA) daily. The DHA + EtOH group was treated with 20 mg/kg/day DHA on day 1 to day 7, and on day 5 to day 7, the rats also received EtOH 1 h after DHA administration using the same EtOH dosages as in the EtOH group. b Schematic representation of LMA measurements on days 5, 6, and 7. Measures were made 2 min before treatment and for 2 min at 45, 90, 135, and 180 min after treatment ACTB β-actin; IL interleukin; NF-κB nuclear factor κB; SFRS4 splicing factor, arginine/serine-rich 4
EtOH treatment from Wk2 revealed long-term effects of EtOH and DHA treatment on LMA. Travel distances were analyzed as a Genotype (2) × EtOH (2) × DHA (2) × blocks (3) mixed ANOVA with blocks as the repeated measure and the three other factors as between-groups factors. The HIV1Tg and F344 groups treated with EtOH showed a decrease in distance traveled over blocks whereas the groups not receiving EtOH did not show this decline (blocks × EtOH interaction: F(2, 70) = 17.05, p < 0.001) (Fig. 2) . However, this effect of EtOH on distance traveled over blocks was prevented by DHA treatment in the HIV-1Tg rats but not the F344 rats as indicated by a statistically significant four-way interaction, F(2, 70) = 3.63, p = 0.03 (Fig. 2) . To further evaluate this four-way interaction, separate three-way ANOVAs (genotype × EtOH × DHA) were conducted on the three blocks separately. The three-way interaction was statistically significant during the third block (Wk4&5) Total distance traveled under the influence of EtOH reveals increased and decreased locomotor activity in F344 and HIV-1Tg rats
Locomotor activity (LMA) in the presence of EtOH was measured for 2 min at 45, 90, 135, and 180 min after EtOH treatment for a total of 8 min per treatment (Fig. 1b) . The distance traveled data for the three blocks (Fig. 3) were analyzed with a four-way ANOVA as in the previous analysis. A genotype (2) × EtOH (2) × DHA (2) × blocks (3) mixed ANOVA did not yield any significant effects of genotype or DHA treatment. The only significant interaction was EtOH × blocks, F(2,70) = 6.69, p = 0.002. This two-way interaction (Fig. 4 ) reflected a decrease in distance traveled from the Wk1 block to the Wk2&3 block (p < 0.001) and the Wk4&5 block (p = 0.02) in the EtOHtreated groups only. Moreover, the EtOH-treated groups traveled a greater distance than No-EtOH-treated groups during Wk1 (p = 0.04), but traveled less than the No-EtOH groups during the Wk2&3 block (p = 0.02); the EtOH-treated and No-EtOH-treated groups did not differ during the Wk4&5 block (p = 0.77) (Fig. 4) .
Thus, EtOH treatment significantly increased locomotor activity the first week of treatment in rats regardless of genotype and DHA treatment, but subsequently decreased locomotor activity with further treatment. The tendency for DHA to reverse the instant effects of EtOH in the HIV-1Tg (Fig. 3) did not reach statistical significance. Fig. 2 Mean travel distance prior to administration of EtOH in the Saline group, DHA group, EtOH group, and DHA + EtOH group in HIV-1Tg rats (a) and F344 rats (b). The data were measured 2 min prior to EtOH administration on EtOH treatment days 5, 6, and 7. Travel distances were analyzed as a Genotype (2) × EtOH (2) × DHA (2) × blocks (3) mixed ANOVA with blocks as the repeated measure and the three other factors as between-groups factors. The HIV-1Tg and F344 groups treated with EtOH showed a decrease in distance traveled over blocks whereas the groups not receiving EtOH did not show this decline (blocks × EtOH interaction: F(2, 70) = 17.05, p < 0.001). LMA decreased consistently over the three blocks in all EtOH-treated groups of both genotypes except the HIV-1Tg DHA + EtOH group Plasma endotoxin concentration is higher in HIV-1Tg rats Plasma endotoxin concentration was tested after 5 weeks of treatment (Fig. 5) . A two-way ANOVA showed no significant interactions between treatment and genotype on plasma endotoxin concentration. No significant differences between groups receiving saline, EtOH, DHA, or DHA + EtOH treatment were observed in either F344 or HIV-1Tg rats. However, there was a statistically significant difference in plasma endotoxin between strains, F(1,31) = 8.859, p = 0.0056.
IL-6, IL-18, and NF-κB gene expression were altered in the striatum
To further explore the molecular mechanism underlying the EtOH and DHA effects, mRNA expression of cytokines IL-6 and IL-18, as well as transcription factor NF-κB, were determined using real-time quantitative PCR. A two-way ANOVA showed no significant interactions between treatment and genotype on IL-6, IL-18, or NF-κB gene expression. As shown in Fig. 6a , b, in HIV-1Tg rats, IL-6 and IL-18 gene expression in the EtOH group were significantly higher than in the DHA group and DHA + EtOH group. NF-κB gene expression was higher in the HIV-1Tg EtOH group than in the HIV-1Tg DHA group or the HIV-1Tg DHA + EtOH group (Fig. 6c) . Notably, the expression of both IL-6 and IL-18 was higher in HIV-1Tg rats given EtOH than in F344 rats treated with EtOH.
Discussion
Epidemiological studies have revealed that people living with HIV (PLWH) in the USA have a high prevalence of alcohol use and abuse . HIV-1Tg rats mimic people living with HIV who are receiving cART (Vigorito et . While HIV virus replication is inhibited via cART, HIV viral proteins persist in the body. This produces systemic inflammation, including neuroinflammation, which ultimately leads to the behavioral disorders associated with HIV infection (Vigorito et al. 2015) . Because DHA is known to be neuroprotective (Dyall 2015; Lauritzen et al. 2016) , we studied whether daily administration of low-dose DHA could reduce the detrimental effects on locomotor activity (LMA) of binge exposure to both EtOH and persistent HIV viral proteins. DHA concentration is higher in females than in males (Giltay et al. 2004) . During the biosynthesis of DHA from precursors, the endogenous conversion of 13 C-labeled ALA into DHA is greater in women than in men . In addition, DHA is reported to be regulated by sex hormones, such as ethinyl estradiol (Giltay et al. 2004 ). The role of DHA has been studied in both males and females . In this study, we explored the effects of DHA in male rats exposed to binge EtOH to avoid potential interference from sex hormones.
LMA data measured prior to EtOH administrations revealed a decrease in distance traveled over blocks in EtOHtreated groups, but not in non-EtOH-treated groups, in both F344 rats (Fig. 2a) and HIV-1Tg rats (Fig. 2b) . This effect of EtOH on travel distance was significantly reduced in EtOHtreated HIV-1Tg rats that also received DHA but not in the F344 rats treated with DHA and EtOH (Fig. 2) . This gradual decrease in LMA was seen in the rats when they were not under the influence of EtOH since the behavioral measures were made before the intragastric treatment for the day, indicating that long-term behavioral changes induced by binge EtOH treatment is reversed only in HIV-1Tg rats.
When HIV-1Tg and F344 rats were tested under the influence of EtOH (after intragastric treatment) there was an initial increase in LMA during the first week (block 1) followed by reduced LMA during weeks 2 and 3 (block 2, Wk2&3). This difference in binge EtOH treatment across blocks may have been partly due to the lower EtOH doses administered during the first 2 days of the first week of treatment to allow the animals to adapt to the high-dose EtOH. The reversal action of DHA on LMA before treatment was also apparent in the HIV-1Tg rats when under the influence of EtOH (Fig. 3) , but this effect failed to reach statistical significance.
DHA was previously reported to exert anti-viral action against HIV by activating the endogenous KCNK channels (Hsu 2009 ). In addition, DHA was found to be involved in the regulation of Nrf2-mediated detoxification mechanisms (Pall and Levine 2015) . Thus, we inferred that LMA was impaired by EtOH and that this detrimental effect was exaggerated by the presence of HIV proteins. This may explain why the HIV-1Tg EtOH group had a significantly shorter travel distance than the F344 EtOH group (Fig. 2) . The antagonistic actions of DHA on the effects of HIV viral proteins might account for DHA's reversal of the combined effects of binge exposure to EtOH and persistent HIV viral proteins. These therapeutic effects of DHA were not evident in F344 rats (Figs. 2 and 3) , presumably because EtOH alone was involved in the decreased LMA in F344 rats.
Binge exposure to EtOH has been reported to increase systemic levels of endotoxin. Repeated binge exposure to EtOH disrupts the intestinal barrier, allowing resident gut bacteria to be released via the intestinal cell walls to enter the bloodstream (Bjarnason et al. 1984) . We found that the plasma endotoxin level of HIV-1Tg rats was significantly higher than that of F344 rats (Fig. 6) . Plasma endotoxin can enhance the penetration of HIV and its proteins, such as gp120, across the blood-brain barrier (BBB) (Banks et al. 1999; Dohgu and Banks 2008) . Peng et al. previously reported that basal expression of HIV viral proteins in brain tissues increases with age (Peng et al. 2010 ). The high plasma endotoxin level in HIV1Tg rats might be the mechanism underlying high expression of HIV proteins in brain tissue. Through both paracellular and transcellular mechanisms, Tat and gp120 HIV-1 viral proteins can alter BBB integrity and function (McRae 2016) , and these effects might allow binge EtOH-induced elevations of plasma endotoxin to leak into brain tissues. Endotoxin in the brain can be degraded into fatty acid and glucosamine residues, which can penetrate into brain tissues (Kim et al. 2014) . Thus, there might be a Bpositive feedback^mechanism underlying how persistent HIV-1 proteins promote elevated plasma endotoxin leakage into the brain tissues, particularly following repeated binge exposure to EtOH. Binge exposure to EtOH also increases the BBB permeability to HIV-1 proteins (Shiu et al. 2007) . Ultimately, the persistence of HIV protein levels and repeated EtOH binging lead to inflammation within the brain. The striatum plays a prominent role in regulating basic motor functions (Grillner et al. 2005) , and impaired LMA implicates striatum dysfunction. The striatum neurons receive input from the cortex, as well as other brain structures including the thalamus, and then project to the output nuclei and other components of the basal ganglia. Neurons in the output nuclei of the basal ganglia in turn project to neurons in the mesencephalic locomotor region (Kiehn and Dougherty 2013) . Therefore, because the striatum is a major input station for the basal ganglia, striatum dysfunction might be involved in the impaired LMA.
Neuroinflammation and neuroimmune signaling have been reported to be associated with neuronal dysfunction (Hong et al. 2016; Park et al. 2017 ). Thus, we tested inflammationrelated gene expression in the striatum. Cytokines, such as IL-6 and IL-18, are markers of inflammation that are secreted by brain cells and known to be related to behavioral dysfunction. In the presence of HIV viral proteins, cytokines are elevated. NF-κB is a protein complex that controls transcription of DNA, cytokine production, and cell survival. When stimulated by IL-18, it subsequently modulates immune-related gene transcription (Alboni et al. 2010) , including transcription of the IL-6 gene (Libermann and Baltimore 1990) . In the present study, neuroinflammation might be related to functional disorders in the striatum following repeated binge exposure to EtOH for 5 weeks. Such prolonged EtOH intoxication from adolescence to early adulthood may cause dysfunction of the striatum, leading to impaired LMA. This speculation is supported by the binge EtOH-induced elevation of immunerelated gene expression, including that of IL-18, IL-6, and NF-κB.
IL-18, a proinflammatory cytokine elevated in HIV-1 infected patients , is produced by and active in brain microglial cells (Prinz and Hanisch 1999) . Increased IL-18 production in the brain is also associated with motor and cognitive dysfunction, leading to the development of HIVassociated dementia (Iannello et al. 2009; von Giesen et al. 2004) . EtOH has also been reported to activate the NLRP3-inflammasome in astroglial cells, which stimulates caspase-1 cleavage and IL-1β and IL-18 production (Alfonso-Loeches et al. 2016 ). IL-6 is a major cytokine in the CNS that is secreted by various brain cells and has a number of physiological functions (Erta et al. 2012) , including behavior regulation (Erta et al. 2015) . Moreover, IL-6 expression was previously reported to be induced by HIV-1 Tat, gp120, and Nef (Del Corno et al. 2014; Liu and Kumar 2015; Nookala and Kumar 2014) . Its level in the CNS is also increased by EtOH exposure (Doremus-Fitzwater et al. 2015; Gano et al. 2016) . The role of NF-κB and its relation to IL-18 and IL-6 was noted above. Furthermore, NF-κB expression correlates with the severity of the AIDS Dementia Complex, a complication of late HIV infection (Rostasy et al. 2000) . In HIV-1Tg rats, IL-6, IL-18, and NF-κB mRNA expression levels in the striatum were highest in the EtOH group (Fig. 6 ). These high expression levels (Fig. 6) were associated with low LMA (Fig. 2b) . As expected, binge EtOH-induced elevations of IL-6, IL-18, and NF-κB mRNA were reversed by treatment with DHA. However, these reversal effects of DHA were not observed in F344 control animals, similar to the results observed for LMA.
Taken together, our results suggest that HIV-1 proteins and high levels of endotoxin in HIV-1Tg rats, particularly when exposed to high-dose EtOH on an intermittent basis to mimic binge alcohol use, might lead to increased expression of inflammation-related genes, such as IL-6, IL-18, and NF-κB, in brain areas including the striatum, which plays a critical role in execution of motor functions. Persistence of HIV viral proteins and binge exposure to EtOH interacted, possibly via neuroinflammation and neuroimmune signaling, to impair LMA. This LMA deficit was partially reversed by treatment with DHA, which attenuated the elevated expression of inflammatory genes, such as IL-6, IL-18, and NF-κB, in the striatum of HIV-1Tg rats.
In conclusion, our research showed that DHA supplements might be a novel way to alleviate the interactive effects of HIV infection and binge drinking through their ability to reduce elevated IL-6, IL-18, and NF-κB expression in the striatum.
